UA8967
UA8967 is a membrane-active antitumor agent. UA8967 exhibits enhanced cytotoxicity against cancer cells harboring a deletion of the tumor suppressor gene DPC4. By disrupting the integrity of the cytoplasmic membrane, UA8967 triggers early caspase-independent autophagy and ultimately leads to non-apoptotic cell lytic death. UA8967 can be used in research on colon cancer and pancreatic cancer.
For research use only. We do not sell to patients.
- CAS No.: 17511-50-1
- Formula: C20H23N3
- Molecular Weight:305.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HpDe6 | IC50 |
41.66 μM
|
Cytotoxicity and growth inhibition against normal immortalized pancreatic epithelial HPDE-6 cells assessed by MTT assay after 72 h incubation.
Cytotoxicity and growth inhibition against normal immortalized pancreatic epithelial HPDE-6 cells assessed by MTT assay after 72 h incubation.
|
23179338 |
In Vitro
UA8967 (72 h) inhibits growth of MiaPaCa-2, Panc-1, BxPC3, CF-PAC1, AsPC1, T3M4, HCT-116 DPC4(+/+), HCT-116 DPC4(−/−), and HPDE-6 cells with IC50 values ranging from 12-61 μM after 72 h, with 4.75-fold greater potency in HCT-116 DPC4(−/−) cells compared to HCT-116 DPC4(+/+) cells[1].
UA8967 (72 h) does not selectively inhibit DNA, RNA, or protein synthesis in MiaPaCa-2 cells, with IC50 values of 40 μM, 40 μM, and 28 μM respectively after 72 h, matching its growth inhibitory potency[1].
UA8967 (0-50 μM; 24-72 h) causes a small accumulation of HCT-116 DPC4+/+ and HCT-116 DPC4−/− cells in G0/G1 phase and a reduction in S-phase cells after 24-48 h, with a more pronounced, dose-dependent S-phase reduction in HCT-116 DPC4−/− cells that persists at 72 h[1].
UA8967 (up to 100 μM; 24 h) induces less than 20% non-apoptotic, non-necrotic cell death in HCT-116 DPC4(+/+) and HCT-116 DPC4(−/−) cells at concentrations up to 100 μM after 24 h, with no caspase activation involved[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT-116 DPC4(+/+) and HCT-116 DPC4(-/-)
-
Concentration:5 μM, 25 μM, 50 μM (24-48 h); 2.5 μM, 5.0 μM, 10.0 μM (72 h)
-
Incubation Time:24 h, 48 h, 72 h
-
Result:Caused a small accumulation of cells in G0/G1 phase and a slight reduction in S-phase cells. The reduction in the percent of cells in S-phase was more pronounced and dose-dependent in the DPC4-deficient HCT-116(-/-) cell line.
-
Cell Line:HCT-116 DPC4(+/+) and HCT-116 DPC4(-/-)
-
Concentration:25 μM, 50 μM, 100 μM
-
Incubation Time:24 h
-
Result:Failed to cause significant necrotic or apoptotic cell death (both less than 20%).
-
Cell Line:MiaPaCa-2, HCT-116 DPC4(+/+), HCT-116 DPC4(−/−)
-
Concentration:50 μM
-
Incubation Time:1, 2, 4, 8, 16, 24 h
-
Result:Increased cleaved LC3 (LC3II, 14 kDa) in a dose- and time-dependent fashion across all tested cell lines.
Showed notable increase in cleaved LC3 as early as 1 h after exposure that continued up to 24 h.
Demonstrated more prominent increase in cleaved LC3 in HCT-116 DPC4(−/−) cells.
-
Cell Line:MiaPaca-2 cells
-
Concentration:100 μM
-
Incubation Time:4 h
-
Result:Induced the formation of autophagic vacuoles.
Chemical Information
-
CAS No. 17511-50-1
-
Molecular Weight 305.42
-
Formula C20H23N3
-
SMILES
C1(CN2CCN(CC2)CC3=CNC4=C3C=CC=C4)=CC=CC=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)